A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group

M.M. Moore, M. Stockler, R. Lim, T.S.K. Mok, Michael Millward, M.J. Boyer

    Research output: Contribution to journalArticle

    23 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)845-850
    JournalCancer Chemotherapy and Pharmacology
    Publication statusPublished - 2010

    Cite this